BIOMAT Database Logo BIOMAT Database Logo

Intraportal islet allografts: the use of a stimulation index to represent functional results. 1991

D W Scharp, and P E Lacy, and L G Weide, and P Marchetti, and C S McCullough, and K Flavin, and J V Santiago
Islet Transplant Center, Washington University Medical Center, St. Louis, MO.

UI MeSH Term Description Entries
D008962 Models, Theoretical Theoretical representations that simulate the behavior or activity of systems, processes, or phenomena. They include the use of mathematical equations, computers, and other electronic equipment. Experimental Model,Experimental Models,Mathematical Model,Model, Experimental,Models (Theoretical),Models, Experimental,Models, Theoretic,Theoretical Study,Mathematical Models,Model (Theoretical),Model, Mathematical,Model, Theoretical,Models, Mathematical,Studies, Theoretical,Study, Theoretical,Theoretical Model,Theoretical Models,Theoretical Studies
D011168 Portal System A system of vessels in which blood, after passing through one CAPILLARY BED, is conveyed through a second set of capillaries before it returns to the systemic circulation. It pertains especially to the hepatic portal system. Portal Systems,System, Portal,Systems, Portal
D001786 Blood Glucose Glucose in blood. Blood Sugar,Glucose, Blood,Sugar, Blood
D002096 C-Peptide The middle segment of proinsulin that is between the N-terminal B-chain and the C-terminal A-chain. It is a pancreatic peptide of about 31 residues, depending on the species. Upon proteolytic cleavage of proinsulin, equimolar INSULIN and C-peptide are released. C-peptide immunoassay has been used to assess pancreatic beta cell function in diabetic patients with circulating insulin antibodies or exogenous insulin. Half-life of C-peptide is 30 min, almost 8 times that of insulin. Proinsulin C-Peptide,C-Peptide, Proinsulin,Connecting Peptide,C Peptide,C Peptide, Proinsulin,Proinsulin C Peptide
D003922 Diabetes Mellitus, Type 1 A subtype of DIABETES MELLITUS that is characterized by INSULIN deficiency. It is manifested by the sudden onset of severe HYPERGLYCEMIA, rapid progression to DIABETIC KETOACIDOSIS, and DEATH unless treated with insulin. The disease may occur at any age, but is most common in childhood or adolescence. Diabetes Mellitus, Brittle,Diabetes Mellitus, Insulin-Dependent,Diabetes Mellitus, Juvenile-Onset,Diabetes Mellitus, Ketosis-Prone,Diabetes Mellitus, Sudden-Onset,Diabetes, Autoimmune,IDDM,Autoimmune Diabetes,Diabetes Mellitus, Insulin-Dependent, 1,Diabetes Mellitus, Type I,Insulin-Dependent Diabetes Mellitus 1,Juvenile-Onset Diabetes,Type 1 Diabetes,Type 1 Diabetes Mellitus,Brittle Diabetes Mellitus,Diabetes Mellitus, Insulin Dependent,Diabetes Mellitus, Juvenile Onset,Diabetes Mellitus, Ketosis Prone,Diabetes Mellitus, Sudden Onset,Diabetes, Juvenile-Onset,Diabetes, Type 1,Insulin Dependent Diabetes Mellitus 1,Insulin-Dependent Diabetes Mellitus,Juvenile Onset Diabetes,Juvenile-Onset Diabetes Mellitus,Ketosis-Prone Diabetes Mellitus,Sudden-Onset Diabetes Mellitus
D003928 Diabetic Nephropathies KIDNEY injuries associated with diabetes mellitus and affecting KIDNEY GLOMERULUS; ARTERIOLES; KIDNEY TUBULES; and the interstitium. Clinical signs include persistent PROTEINURIA, from microalbuminuria progressing to ALBUMINURIA of greater than 300 mg/24 h, leading to reduced GLOMERULAR FILTRATION RATE and END-STAGE RENAL DISEASE. Diabetic Glomerulosclerosis,Glomerulosclerosis, Diabetic,Diabetic Kidney Disease,Diabetic Nephropathy,Intracapillary Glomerulosclerosis,Kimmelstiel-Wilson Disease,Kimmelstiel-Wilson Syndrome,Nodular Glomerulosclerosis,Diabetic Kidney Diseases,Glomerulosclerosis, Nodular,Kidney Disease, Diabetic,Kidney Diseases, Diabetic,Kimmelstiel Wilson Disease,Kimmelstiel Wilson Syndrome,Nephropathies, Diabetic,Nephropathy, Diabetic,Syndrome, Kimmelstiel-Wilson
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D014184 Transplantation, Homologous Transplantation between individuals of the same species. Usually refers to genetically disparate individuals in contradistinction to isogeneic transplantation for genetically identical individuals. Transplantation, Allogeneic,Allogeneic Grafting,Allogeneic Transplantation,Allografting,Homografting,Homologous Transplantation,Grafting, Allogeneic
D016030 Kidney Transplantation The transference of a kidney from one human or animal to another. Grafting, Kidney,Renal Transplantation,Transplantation, Kidney,Transplantation, Renal,Kidney Grafting,Kidney Transplantations,Renal Transplantations,Transplantations, Kidney,Transplantations, Renal
D016381 Islets of Langerhans Transplantation The transference of pancreatic islets within an individual, between individuals of the same species, or between individuals of different species. Grafting, Islets of Langerhans,Pancreatic Islets Transplantation,Transplantation, Islets of Langerhans,Transplantation, Pancreatic Islets,Islands of Langerhans Transplantation,Islands of Pancreas Transplantation,Islet Transplantation,Transplantation, Islands of Langerhans,Transplantation, Islands of Pancreas,Transplantation, Islet,Islet Transplantations,Islets Transplantation, Pancreatic,Transplantations, Islet

Related Publications

D W Scharp, and P E Lacy, and L G Weide, and P Marchetti, and C S McCullough, and K Flavin, and J V Santiago
Reinnervation of intraportal islet allografts in rats.
March 1993, Transplantation,
D W Scharp, and P E Lacy, and L G Weide, and P Marchetti, and C S McCullough, and K Flavin, and J V Santiago
Sequential intraportal islet allografts in immunosuppressed type I diabetic patients: preliminary results.
March 2000, Transplantation proceedings,
D W Scharp, and P E Lacy, and L G Weide, and P Marchetti, and C S McCullough, and K Flavin, and J V Santiago
Intraportal islet allografts in type I diabetes mellitus.
June 1992, Transplantation proceedings,
D W Scharp, and P E Lacy, and L G Weide, and P Marchetti, and C S McCullough, and K Flavin, and J V Santiago
Prolonged survival of intraportal versus subrenal capsular transplanted islet allografts.
May 1987, Transplantation,
D W Scharp, and P E Lacy, and L G Weide, and P Marchetti, and C S McCullough, and K Flavin, and J V Santiago
Effect of intraportal human islet transplantation on kidney graft survival in simultaneous kidney-islet allografts.
February 1993, Transplantation proceedings,
D W Scharp, and P E Lacy, and L G Weide, and P Marchetti, and C S McCullough, and K Flavin, and J V Santiago
Insulin independence after allogeneic intraportal islet transplantation: relation to functional tests.
March 1998, Transplantation proceedings,
D W Scharp, and P E Lacy, and L G Weide, and P Marchetti, and C S McCullough, and K Flavin, and J V Santiago
Intraportal islet transplantation: functional assessment in conscious unrestrained rats.
March 1980, Endocrinology,
D W Scharp, and P E Lacy, and L G Weide, and P Marchetti, and C S McCullough, and K Flavin, and J V Santiago
Induction of donor specific unresponsiveness in rat islet allografts by intraportal grafting and FK506.
January 1994, Cell transplantation,
D W Scharp, and P E Lacy, and L G Weide, and P Marchetti, and C S McCullough, and K Flavin, and J V Santiago
Magnetic resonance-defined periportal steatosis following intraportal islet transplantation: a functional footprint of islet graft survival?
July 2003, Diabetes,
D W Scharp, and P E Lacy, and L G Weide, and P Marchetti, and C S McCullough, and K Flavin, and J V Santiago
Use of D-STAT to prevent bleeding following percutaneous transhepatic intraportal islet transplantation.
January 2004, Cell transplantation,
Copied contents to your clipboard!